Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3635485)

Published in Methods Enzymol on January 01, 2011

Authors

Joshua J Ziarek1, Francis C Peterson, Betsy L Lytle, Brian F Volkman

Author Affiliations

1: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Articles citing this

Orphan macrodomain protein (human C6orf130) is an O-acyl-ADP-ribose deacylase: solution structure and catalytic properties. J Biol Chem (2011) 1.12

Sulfotyrosine recognition as marker for druggable sites in the extracellular space. Int J Mol Sci (2011) 0.85

LigandRFs: random forest ensemble to identify ligand-binding residues from sequence information alone. BMC Bioinformatics (2014) 0.85

Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery. ACS Chem Biol (2013) 0.85

Mechanism of N-Acylthiourea-mediated activation of human histone deacetylase 8 (HDAC8) at molecular and cellular levels. J Biol Chem (2015) 0.83

Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface. J Med Chem (2016) 0.83

Secondary Structure Analysis of a Functional Construct of Caveolin-1 Reveals a Long C-Terminal Helix. Biophys J (2015) 0.80

Interaction studies of the human and Arabidopsis thaliana Med25-ACID proteins with the herpes simplex virus VP16- and plant-specific Dreb2a transcription factors. PLoS One (2014) 0.79

Protein-Inhibitor Interaction Studies Using NMR. Appl NMR Spectrosc (2015) 0.78

Determination of ligand binding modes in weak protein-ligand complexes using sparse NMR data. J Biomol NMR (2016) 0.76

NMR reveals structural rearrangements associated to substrate insertion in nucleotide-adding enzymes. Protein Sci (2016) 0.76

NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery. Drug Discov Today Technol (2012) 0.75

Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins. J Biol Chem (2016) 0.75

Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1. PLoS One (2017) 0.75

Molecular Basis for the Interaction Between AP4 β4 and its Accessory Protein, Tepsin. Traffic (2016) 0.75

Articles cited by this

(truncated to the top 100)

NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94

MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73

Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86

ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75

TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR (2009) 16.09

Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol (1997) 15.40

Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A (1997) 13.28

Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol (2002) 11.20

Automated NMR structure calculation with CYANA. Methods Mol Biol (2004) 9.31

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov (2004) 7.84

A fast flexible docking method using an incremental construction algorithm. J Mol Biol (1996) 7.33

Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 7.10

Refinement of protein structures in explicit solvent. Proteins (2003) 5.31

A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov (2007) 4.82

DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54

ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics (2006) 3.70

GFT NMR, a new approach to rapidly obtain precise high-dimensional NMR spectral information. J Am Chem Soc (2003) 3.21

A simple method to predict protein flexibility using secondary chemical shifts. J Am Chem Soc (2005) 3.15

Probabilistic interaction network of evidence algorithm and its application to complete labeling of peak lists from protein NMR spectroscopy. PLoS Comput Biol (2009) 3.01

NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed Engl (2003) 2.98

ARIA: automated NOE assignment and NMR structure calculation. Bioinformatics (2003) 2.90

Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86

Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. J Am Chem Soc (2005) 2.81

SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds. J Biomol NMR (2005) 2.53

Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal (2008) 2.33

Accelerated acquisition of high resolution triple-resonance spectra using non-uniform sampling and maximum entropy reconstruction. J Magn Reson (2004) 2.30

Mars -- robust automatic backbone assignment of proteins. J Biomol NMR (2004) 2.22

A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics. J Biomol NMR (2002) 2.21

Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins. J Mol Biol (1999) 2.13

Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinib. J Biol Chem (2008) 2.09

Automated protein structure determination from NMR spectra. J Am Chem Soc (2006) 1.96

Automated structure determination from NMR spectra. Eur Biophys J (2008) 1.94

Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J Mol Biol (1995) 1.93

The acquisition of multidimensional NMR spectra within a single scan. Proc Natl Acad Sci U S A (2002) 1.93

Gaussian docking functions. Biopolymers (2003) 1.82

Optimizing resolution in multidimensional NMR by three-way decomposition. J Biomol NMR (2003) 1.81

High-resolution iterative frequency identification for NMR as a general strategy for multidimensional data collection. J Am Chem Soc (2005) 1.79

A topology-constrained distance network algorithm for protein structure determination from NOESY data. Proteins (2006) 1.79

Cell-free protein production and labeling protocol for NMR-based structural proteomics. Nat Methods (2004) 1.78

Auto-induction medium for the production of [U-15N]- and [U-13C, U-15N]-labeled proteins for NMR screening and structure determination. Protein Expr Purif (2005) 1.65

High-throughput purification and quality assurance of Arabidopsis thaliana proteins for eukaryotic structural genomics. J Struct Funct Genomics (2005) 1.65

Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J Mol Biol (2006) 1.63

Small-molecule inhibitors of protein-protein interactions. Curr Opin Drug Discov Devel (2008) 1.63

Automated peak picking and peak integration in macromolecular NMR spectra using AUTOPSY. J Magn Reson (1998) 1.62

Resolution and sensitivity of high field nuclear magnetic resonance spectroscopy. J Biomol NMR (2004) 1.60

Automated sequence-specific protein NMR assignment using the memetic algorithm MATCH. J Biomol NMR (2008) 1.59

PINE-SPARKY: graphical interface for evaluating automated probabilistic peak assignments in protein NMR spectroscopy. Bioinformatics (2009) 1.59

Three-dimensional pharmacophore methods in drug discovery. J Med Chem (2010) 1.58

The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci (2005) 1.57

Predicting druggable binding sites at the protein-protein interface. Drug Discov Today (2008) 1.45

Combined chemical shift changes and amino acid specific chemical shift mapping of protein-protein interactions. J Biomol NMR (2007) 1.44

Automated analysis of protein NMR assignments and structures. Chem Rev (2004) 1.43

NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem (1997) 1.41

Solution structure of a ubiquitin-like domain from tubulin-binding cofactor B. J Biol Chem (2004) 1.40

An integrated platform for automated analysis of protein NMR structures. Methods Enzymol (2005) 1.35

Discovering high-affinity ligands for proteins. Science (1997) 1.33

An automated tool for maximum entropy reconstruction of biomolecular NMR spectra. Nat Methods (2007) 1.31

PICKY: a novel SVD-based NMR spectra peak picking method. Bioinformatics (2009) 1.31

Comparison of cell-based and cell-free protocols for producing target proteins from the Arabidopsis thaliana genome for structural studies. Proteins (2005) 1.26

Automated assignment of simulated and experimental NOESY spectra of proteins by feedback filtering and self-correcting distance geometry. J Mol Biol (1995) 1.21

eHiTS: an innovative approach to the docking and scoring function problems. Curr Protein Pept Sci (2006) 1.21

G-matrix Fourier transform NOESY-based protocol for high-quality protein structure determination. J Am Chem Soc (2005) 1.18

NMR methods for the determination of protein-ligand dissociation constants. Curr Top Med Chem (2003) 1.17

Organic solvents identify specific ligand binding sites on protein surfaces. Nat Biotechnol (1997) 1.16

High-throughput nuclear magnetic resonance-based screening. J Med Chem (1999) 1.15

Influence of the completeness of chemical shift assignments on NMR structures obtained with automated NOE assignment. J Struct Funct Genomics (2003) 1.14

Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design. J Am Chem Soc (2010) 1.12

Automated protein structure calculation from NMR data. J Biomol NMR (2009) 1.12

An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity. Biochemistry (2007) 1.11

Structure of the B3 domain from Arabidopsis thaliana protein At1g16640. Protein Sci (2005) 1.11

Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments. J Am Chem Soc (2004) 1.11

ABACUS, a direct method for protein NMR structure computation via assembly of fragments. Proteins (2005) 1.10

Solution structure of thioredoxin h1 from Arabidopsis thaliana. Protein Sci (2005) 1.07

A probabilistic approach for validating protein NMR chemical shift assignments. J Biomol NMR (2010) 1.05

Automation of NMR structure determination of proteins. Curr Opin Struct Biol (2004) 1.05

Structure of the Ras-binding domain of RalGEF and implications for Ras binding and signalling. Nat Struct Biol (1997) 1.03

Distal interactions within the par3-VE-cadherin complex. Biochemistry (2010) 1.00

Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP. J Biol Chem (2007) 1.00

Nuclear magnetic resonance chromatography: applications of pulse field gradient diffusion NMR to mixture analysis and ligand-receptor interactions. J Chromatogr B Biomed Sci Appl (1999) 1.00

Sequence-specific assignment of aromatic resonances of uniformly 13C,15N-labeled proteins by using 13C- and 15N-edited NOESY spectra. Angew Chem Int Ed Engl (2006) 0.97

Small-scale, semi-automated purification of eukaryotic proteins for structure determination. J Struct Funct Genomics (2007) 0.96

A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface. Structure (2010) 0.95

Nuclear magnetic resonance-based approaches for lead generation in drug discovery. Methods Enzymol (2001) 0.93

Structure of the SCAN domain from the tumor suppressor protein MZF1. J Mol Biol (2006) 0.92

NMR distinction of single- and multiple-mode binding of small-molecule protein ligands. J Am Chem Soc (2006) 0.92

Pharmacophores incorporating numerous excluded volumes defined by X-ray crystallographic structure in three-dimensional database searching: application to the thyroid hormone receptor. J Med Chem (1998) 0.92

Production in two-liter beverage bottles of proteins for NMR structure determination labeled with either 15N- or 13C-15N. J Struct Funct Genomics (2004) 0.91

Real-time monitoring of chemical transformations by ultrafast 2D NMR spectroscopy. J Am Chem Soc (2006) 0.89

Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins. J Biomol NMR (2000) 0.88

The Center for Eukaryotic Structural Genomics. J Struct Funct Genomics (2009) 0.87

Automated error-tolerant macromolecular structure determination from multidimensional nuclear Overhauser enhancement spectra and chemical shift assignments: improved robustness and performance of the PASD algorithm. J Biomol NMR (2008) 0.87

Mapping the surface of Escherichia coli peptide deformylase by NMR with organic solvents. Protein Sci (2002) 0.85

Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery. J Chem Inf Model (2008) 0.85

Fully automated sequence-specific resonance assignments of hetero- nuclear protein spectra. J Biomol NMR (2003) 0.85

Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. J Chem Inf Model (2006) 0.84

Automated sequencing of amino acid spin systems in proteins using multidimensional HCC(CO)NH-TOCSY spectroscopy and constraint propagation methods from artificial intelligence. J Biomol NMR (1994) 0.84

Detailed NMR analysis of the heme-protein interactions in component IV Glycera dibranchiata monomeric hemoglobin-CO. J Biomol NMR (1998) 0.81

Solution structure of Arabidopsis thaliana protein At5g39720.1, a member of the AIG2-like protein family. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81

Articles by these authors

Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family of START proteins. Science (2009) 10.21

A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature (2009) 3.63

Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal (2008) 2.33

Project management system for structural and functional proteomics: Sesame. J Struct Funct Genomics (2003) 2.19

Interconversion between two unrelated protein folds in the lymphotactin native state. Proc Natl Acad Sci U S A (2008) 2.17

Unfolding of the C-terminal domain of the J-protein Zuo1 releases autoinhibition and activates Pdr1-dependent transcription. J Mol Biol (2012) 2.04

Cdc42 regulates the Par-6 PDZ domain through an allosteric CRIB-PDZ transition. Mol Cell (2004) 1.95

Cell-free protein production and labeling protocol for NMR-based structural proteomics. Nat Methods (2004) 1.78

Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell (2002) 1.70

Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J Mol Biol (2006) 1.63

Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc Natl Acad Sci U S A (2011) 1.58

The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci (2005) 1.57

Altered dimer interface decreases stability in an amyloidogenic protein. J Biol Chem (2008) 1.50

Heterodimer formation of the myeloid zinc finger 1 SCAN domain and association with promyelocytic leukemia nuclear bodies. Leuk Res (2008) 1.48

Activation of dimeric ABA receptors elicits guard cell closure, ABA-regulated gene expression, and drought tolerance. Proc Natl Acad Sci U S A (2013) 1.47

Structural basis for selective activation of ABA receptors. Nat Struct Mol Biol (2010) 1.43

Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J Biol Chem (2004) 1.42

Solution structure of a ubiquitin-like domain from tubulin-binding cofactor B. J Biol Chem (2004) 1.40

Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J Biol Chem (2002) 1.36

The NMR solution structure of BeF(3)(-)-activated Spo0F reveals the conformational switch in a phosphorelay system. J Mol Biol (2003) 1.32

Structural and functional insights into core ABA signaling. Curr Opin Plant Biol (2010) 1.29

Comparison of cell-based and cell-free protocols for producing target proteins from the Arabidopsis thaliana genome for structural studies. Proteins (2005) 1.26

Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4. Proc Natl Acad Sci U S A (2012) 1.25

The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. J Biol Chem (2011) 1.23

The crystal structure and catalytic mechanism of cellobiohydrolase CelS, the major enzymatic component of the Clostridium thermocellum Cellulosome. J Mol Biol (2002) 1.23

Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. Biochemistry (2008) 1.20

Macromolecular structure determination by NMR spectroscopy. Methods Biochem Anal (2003) 1.16

Potent and selective activation of abscisic acid receptors in vivo by mutational stabilization of their agonist-bound conformation. Proc Natl Acad Sci U S A (2011) 1.14

Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Sci (2009) 1.13

Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design. J Am Chem Soc (2010) 1.12

Orphan macrodomain protein (human C6orf130) is an O-acyl-ADP-ribose deacylase: solution structure and catalytic properties. J Biol Chem (2011) 1.12

Structure of the B3 domain from Arabidopsis thaliana protein At1g16640. Protein Sci (2005) 1.11

An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity. Biochemistry (2007) 1.11

Solution structure of thioredoxin h1 from Arabidopsis thaliana. Protein Sci (2005) 1.07

On-column refolding of recombinant chemokines for NMR studies and biological assays. Protein Expr Purif (2006) 1.05

A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability. Mol Cancer Ther (2012) 1.02

Distal interactions within the par3-VE-cadherin complex. Biochemistry (2010) 1.00

A novel zinc finger is required for Mcm10 homocomplex assembly. J Biol Chem (2003) 1.00

Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J Biol Chem (2012) 1.00

Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP. J Biol Chem (2007) 1.00

Native-state interconversion of a metamorphic protein requires global unfolding. Biochemistry (2011) 0.97

Chapter 3. Lymphotactin structural dynamics. Methods Enzymol (2009) 0.97

Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics. J Struct Funct Genomics (2007) 0.96

Solution structure of CCL21 and identification of a putative CCR7 binding site. Biochemistry (2012) 0.96

Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. Blood (2011) 0.95

A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface. Structure (2010) 0.95

Diversity of polyproline recognition by EVH1 domains. Front Biosci (Landmark Ed) (2009) 0.95

The solution structure of ZNF593 from Homo sapiens reveals a zinc finger in a predominantly unstructured protein. Protein Sci (2008) 0.95

Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome. J Mol Biol (2006) 0.93

Structure of the SCAN domain from the tumor suppressor protein MZF1. J Mol Biol (2006) 0.92

Structural basis for recognition of phosphodiester-containing lysosomal enzymes by the cation-independent mannose 6-phosphate receptor. Proc Natl Acad Sci U S A (2010) 0.92

Production in two-liter beverage bottles of proteins for NMR structure determination labeled with either 15N- or 13C-15N. J Struct Funct Genomics (2004) 0.91

Conversion of the enzyme guanylate kinase into a mitotic-spindle orienting protein by a single mutation that inhibits GMP-induced closing. Proc Natl Acad Sci U S A (2011) 0.90

The first structure from the SOUL/HBP family of heme-binding proteins, murine P22HBP. J Biol Chem (2006) 0.89

Structures of two Arabidopsis thaliana major latex proteins represent novel helix-grip folds. Proteins (2009) 0.88

Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase. J Biol Chem (2013) 0.88

Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface. J Biol Chem (2012) 0.88

The Center for Eukaryotic Structural Genomics. J Struct Funct Genomics (2009) 0.87

Structure of the hypothetical protein At3g17210 from Arabidopsis thaliana. J Biomol NMR (2004) 0.86

Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. Biochemistry (2013) 0.86

Electrostatic optimization of the conformational energy landscape in a metamorphic protein. Biochemistry (2012) 0.86